AUG 1, 2026 · JOURNAL ARTICLE
Loss of NCCRP1 overcomes immune evasion in lung adenocarcinoma
Journal for Immunotherapy of Cancer
Preclinical mechanistic study in mouse models demonstrating that NCCRP1 loss enhances anti-tumor immunity and synergizes with checkpoint inhibition, but findings require translation to human clinical trials.
Reported
Efficacy endpointcomplete tumor eradication